Guardian Pharmacy Services (GRDN) Stock Price, News & Analysis

Company Overview

Guardian Pharmacy Services, Inc. is a long-term care pharmacy company that provides prescription medications and related pharmacy services to residents of assisted living communities, skilled nursing facilities, memory care centers and other institutional care settings.

The company’s services include medication dispensing and packaging, prescription delivery, medication management, pharmacy consulting and clinical support. Guardian works with care providers, residents and their families to help coordinate medication regimens, improve adherence and support the ongoing pharmacy needs of patients who may require complex or recurring treatments.

Guardian Pharmacy Services operates through a network of community-based pharmacies serving long-term care customers in multiple U.S. markets. The company was established in the 2000s and has expanded its network through a combination of organic growth and partnerships or acquisitions involving regional pharmacy operators.

Key Stats

• Today's Range: $44.24 to $45.64
• 50-Day Range: $37.05 to $48.11
• 52-Week Range: $23.14 to $48.33
• Volume: 3.21 million shs
• Average Volume: 652,480 shs
• Market Capitalization: $2.24 billion
• P/E Ratio: 43.71
• Dividend Yield: N/A
• Price Target: $43.83
• Consensus Rating: Moderate Buy

Guardian Pharmacy Services Stock Analysis - MarketRank™

Guardian Pharmacy Services scored higher than 24% of companies evaluated by MarketBeat, and ranked 762nd out of 895 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 1.8 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

Guardian Pharmacy Services has received a consensus rating of Moderate Buy. The company's average rating score is 2.89, and is based on no strong buy ratings, 8 buy ratings, 1 hold rating, and no sell ratings.

Upside/Downside

The consensus price target for Guardian Pharmacy Services is close to its current price, suggesting limited near-term upside or downside.

Amount of Analyst Coverage

Guardian Pharmacy Services has only been the subject of 2 research reports in the past 90 days.

Earnings and Valuation

• Score: 1.9 / 5
• Proj. Earnings Growth: 14.29%

Earnings Growth

Earnings for Guardian Pharmacy Services are expected to grow by 14.29% in the coming year, from $1.19 to $1.36 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Guardian Pharmacy Services is 43.71, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 38.95.

Price to Earnings Ratio vs. Sector

The P/E ratio of Guardian Pharmacy Services is 43.71, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 275.51.

Price to Earnings Growth Ratio

Guardian Pharmacy Services has a PEG Ratio of 2.33. PEG Ratios above 1 indicate that a company could be overvalued.

Price to Book Value per Share Ratio

Guardian Pharmacy Services has a P/B Ratio of 13.09. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: 1.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

9.11% of the float of Guardian Pharmacy Services has been sold short.

Short Interest Ratio / Days to Cover

Guardian Pharmacy Services has a short interest ratio ("days to cover") of 9.41.

Change versus previous month

Short interest in Guardian Pharmacy Services has recently increased by 1.16%, indicating that investor sentiment is decreasing.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Guardian Pharmacy Services does not currently pay a dividend.

Dividend Growth

Guardian Pharmacy Services does not have a long track record of dividend growth.

News and Social Media

• Score: 1.2 / 5
• News Sentiment: -0.07

News Sentiment

Guardian Pharmacy Services has a news sentiment score of -0.07. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.54 average news sentiment score of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 3 news articles for Guardian Pharmacy Services this week, compared to 2 articles on an average week.

Search Interest

Only 1 people have searched for GRDN on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.

MarketBeat Follows

Only 1 people have added Guardian Pharmacy Services to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.

Company Ownership

• Score: 0.7 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Guardian Pharmacy Services insiders have not sold or bought any company stock.

Percentage Held by Insiders

32.96% of the stock of Guardian Pharmacy Services is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

Guardian Pharmacy Services has minimal institutional ownership at this time.

Company Calendar

• Last Earnings: 8/06/2026
• Today: 9/20/2026
• Next Earnings (Estimated): 11/09/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Healthcare
• Industry: Healthcare Providers & Services
• Sub-Industry: Healthcare Services
• Current Symbol: NYSE:GRDN
• Previous Symbol: NYSE:GRDN
• CIK: 1802255
• Web: guardianpharmacy.com
• Phone: (404) 810-0089
• Fax: N/A
• Employees: 3,600
• Year Founded: 2004

Price Target and Rating

• Average Price Target for Guardian Pharmacy Services: $43.83
• High Price Target: $49.00
• Low Price Target: $36.00
• Potential Upside/Downside: -2.6%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.89
• Research Coverage: 9 Analysts

Profitability

• EPS (Trailing Twelve Months): $1.03
• Trailing P/E Ratio: 43.71
• Forward P/E Ratio: 37.83
• P/E Growth: 2.33
• Net Income: $49.22 million
• Net Margins: 4.50%
• Pretax Margin: 6.55%
• Return on Equity: 29.97%
• Return on Assets: 16.18%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 1.65
• Quick Ratio: 1.33

Sales & Book Value

• Annual Sales: $1.45 billion
• Price / Sales: 1.55
• Cash Flow: $1.26 per share
• Price / Cash Flow: 35.72
• Book Value: $3.44 per share
• Price / Book: 13.09

Miscellaneous

• Outstanding Shares: 49,800,000
• Free Float: 33,385,000
• Market Cap: $2.24 billion
• Optionable: N/A
• Beta: 0.06